JUBLINGREA2023-01-012023-03-31 JUBLINGREA2023-01-012023-03-31 JUBLINGREA2023-01-012023-03-31in-bse-fin:OneOperatingExpenses01Member JUBLINGREA2023-01-012023-03-31in-bse-fin:OneOperatingExpenses02Member JUBLINGREA2023-01-012023-03-31in-bse-fin:FourOperatingExpenses01Member JUBLINGREA2023-01-012023-03-31in-bse-fin:FourOperatingExpenses02Member JUBLINGREA2023-03-31 JUBLINGREA2023-01-012023-03-31in-bse-fin:OneReportableSegmentRevenue01Member JUBLINGREA2023-01-012023-03-31in-bse-fin:OneReportableSegmentRevenue02Member JUBLINGREA2023-01-012023-03-31in-bse-fin:OneReportableSegmentRevenue03Member JUBLINGREA2023-01-012023-03-31in-bse-fin:FourReportableSegmentRevenue01Member JUBLINGREA2023-01-012023-03-31in-bse-fin:FourReportableSegmentRevenue02Member JUBLINGREA2023-01-012023-03-31in-bse-fin:FourReportableSegmentRevenue03Member JUBLINGREA2023-01-012023-03-31in-bse-fin:OneReportableSegmentResults01Member JUBLINGREA2023-01-012023-03-31in-bse-fin:OneReportableSegmentResults02Member JUBLINGREA2023-01-012023-03-31in-bse-fin:OneReportableSegmentResults03Member JUBLINGREA2023-01-012023-03-31in-bse-fin:FourReportableSegmentResults01Member JUBLINGREA2023-01-012023-03-31in-bse-fin:FourReportableSegmentResults02Member JUBLINGREA2023-01-012023-03-31in-bse-fin:FourReportableSegmentResults03Member JUBLINGREA2023-01-012023-03-31in-bse-fin:OneReportableSegmentAssets01Member JUBLINGREA2023-01-012023-03-31in-bse-fin:OneReportableSegmentAssets02Member JUBLINGREA2023-01-012023-03-31in-bse-fin:OneReportableSegmentAssets03Member JUBLINGREA2023-01-012023-03-31in-bse-fin:OneReportableSegmentLiabilities01Member JUBLINGREA2023-03-31in-bse-fin:OneReportableSegmentLiabilities01Member JUBLINGREA2023-01-012023-03-31in-bse-fin:OneReportableSegmentLiabilities02Member JUBLINGREA2023-03-31in-bse-fin:OneReportableSegmentLiabilities02Member JUBLINGREA2023-01-012023-03-31in-bse-fin:OneReportableSegmentLiabilities03Member JUBLINGREA2023-03-31in-bse-fin:OneReportableSegmentLiabilities03Member JUBLINGREA2023-01-012023-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member JUBLINGREA2023-01-012023-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member JUBLINGREA2023-01-012023-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member JUBLINGREA2023-01-012023-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 543271 JUBLINGREA NOTLISTED Jubilant Ingrevia Limited Equity 2022-04-01 2023-03-31 2023-05-16 2023-05-08 INR Lakhs Yearly 11:30:00 14:00:00 2023-05-16 2023-05-16 true Cash Flow Indirect Declaration of unmodified opinion Multi segment 2023-01-01 2023-03-31 Audited Consolidated 11449800000.00 90000000.00 11539800000.00 5448600000.00 544700000.00 485500000.00 860200000.00 57000000.00 298400000.00 3090300000.00 10784700000.00 755100000.00 100000.00 755200000.00 115000000.00 117100000.00 232100000.00 0.00 523100000.00 0.00 0.00 0.00 0.00 523100000.00 31000000.00 554100000.00 523100000.00 0.00 31000000.00 554100000.00 159000000.00 1 3.29 3.29 0.00 0.00 3.29 3.29 0.00 Multi segment 2022-04-01 2023-03-31 Audited Consolidated 47726900000.00 333700000.00 48060600000.00 25477600000.00 1615500000.00 -1277400000.00 3434800000.00 215800000.00 1221800000.00 13005000000.00 43693100000.00 4367500000.00 -400000.00 4367100000.00 702300000.00 589800000.00 1292100000.00 0.00 3075000000.00 0.00 0.00 0.00 0.00 3075000000.00 24000000.00 3099000000.00 3075000000.00 0.00 24000000.00 3099000000.00 159000000.00 1 26503300000.00 19.34 19.33 0.00 0.00 19.34 19.33 0.00 Others 1587300000.00 Power and Fuel Expenses 1503000000.00 Others 5913900000.00 Power and Fuel Expenses 7091100000.00 17878000000.00 5249300000.00 0.00 0.00 583700000.00 0.00 0.00 50600000.00 31800000.00 4400000.00 37900000.00 74100000.00 98900000.00 474200000.00 24408800000.00 10351100000.00 0.00 5108900000.00 727300000.00 118600000.00 5300000.00 229600000.00 6189700000.00 11400000.00 1627800000.00 18180000000.00 0.00 0.00 42588800000.00 159000000.00 26503300000.00 26662300000.00 26662300000.00 1500000000.00 69900000.00 1569900000.00 661300000.00 1899500000.00 4130700000.00 2467300000.00 8011200000.00 911300000.00 11389800000.00 190400000.00 202500000.00 13100000.00 11795800000.00 15926500000.00 42588800000.00 7. The Holding Company does not have any outstanding commercial papers as at 31 March 2023. Subsequent to the quarter-end, the Company has issued unsecured listed commercial papers (CPs) of Rs. 10000 lakhs which are listed on the National Stock Exchange of India. Details of CPs are as follows ISIN No. Issue date Due date of repayment Redemption amount INEOBY014136 20 April 2023 29 June 2023 ` 5000 lakhs INEOBY014151 3 May 2023 26 June 2023 ` 5000 lakhs 8. Subsequent to quarter ended 31 March 2023, the Holding Company has commissioned new ‘Acetic Anhydride’ plant at Bharuch, Gujarat. 9. The figures for the quarter ended 31 March 2023 and quarter ended 31 March 2022, as reported in the consolidated financial results, are the balancing figures between the audited figures for the year ended 31 March 2023 and 31 March 2022 and the published year to date figures for 31 December 2022 and 31 December 2021, which were subjected to limited review by the statutory auditors. 10. Previous periods/year figures have been regrouped/reclassified to conform to the current period/year classification. 11. The above consolidated audited financial results were reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on 16 May 2023. The audit report of the Statutory Auditors is being filed with the BSE Limited and The National Stock Exchange of India Limited. For more details on consolidated audited results, visit Investors section of our website at www.jubilantingrevia.com and Financial Results at Corporates section of www.nseindia.com and www.bseindia.com. Chemical Intermediates 5241800000.00 Nutrition & Health Solutions 1552300000.00 Speciality Chemicals 5142700000.00 Chemical Intermediates 24660200000.00 Nutrition & Health Solutions 5511700000.00 Speciality Chemicals 19811800000.00 11936800000.00 49983700000.00 487000000.00 2256800000.00 11449800000.00 47726900000.00 Chemical Intermediates 498700000.00 Nutrition & Health Solutions 15800000.00 Speciality Chemicals 380400000.00 Chemical Intermediates 2436600000.00 Nutrition & Health Solutions 326400000.00 Speciality Chemicals 2151900000.00 894900000.00 4914900000.00 57000000.00 215800000.00 82700000.00 332000000.00 755200000.00 4367100000.00 Chemical Intermediates 13725600000.00 Nutrition & Health Solutions 4455300000.00 Speciality Chemicals 23038100000.00 41219000000.00 1369800000.00 42588800000.00 Chemical Intermediates 3980600000.00 Nutrition & Health Solutions 810800000.00 Speciality Chemicals 5246000000.00 10037400000.00 5889100000.00 15926500000.00 215800000.00 -1258400000.00 0.00 1140000000.00 0.00 0.00 0.00 0.00 0.00 -333100000.00 0.00 0.00 0.00 1221800000.00 0.00 0.00 0.00 0.00 0.00 12200000.00 0.00 12400000.00 26900000.00 0.00 0.00 -1000000.00 4900000.00 14200000.00 400000.00 1031300000.00 5398400000.00 0.00 0.00 0.00 773800000.00 0.00 4624600000.00 0.00 0.00 0.00 21200000.00 0.00 0.00 0.00 0.00 0.00 4813900000.00 32100000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 11100000.00 0.00 73000000.00 0.00 -4718900000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2676600000.00 1000000000.00 0.00 27500000.00 793100000.00 440000000.00 0.00 0.00 416000000.00 321700000.00 29500000.00 351200000.00 376100000.00 727300000.00 Items that will not be classified to profit or loss 6700000.00 Items that will not be classified to profit or loss -16600000.00 6700000.00 -16600000.00 4300000.00 -2700000.00 Items that will be reclassified to profit or loss 37100000.00 Items that will be reclassified to profit or loss 32300000.00 37100000.00 32300000.00 8500000.00 -5600000.00